Search Result "Pfizer"
Development of Dermatomyositis after Pfizer BioNTeh COVID-19Vaccine: A Case Report
Journal: Current Drug Safety
Volume: 19 Issue: 2 Year: 2024 Page: 306-308
Author(s):
Erythema Multiforme Reactions Following Pfizer/BioNTech (Tozinameran)Vaccination: Two Case-Reports with Positive Rechallenge and Review ofthe Literature
Journal: Current Drug Safety
Volume: 19 Issue: 4 Year: 2024 Page: 465-468
Author(s): Sihem EL Aidli
Experiences in Implementing uHTS - Cutting Edge Technology Meets the Real World
Journal: Current Drug Discovery Technologies
Volume: 1 Issue: 1 Year: 2004 Page: 27-35
Author(s): Philip Gribbon, Sabine Schaertl, Malcolm Wickenden, Gareth Williams, Rachel Grimley, Frank Stuhmeier, Hartwig Preckel, Christian Eggeling, Joachim Kraemer, Jeremy Everett
Anti-Coronavirus Vaccines: Past Investigations on SARS-CoV-1 andMERS-CoV, the Approved Vaccines from BioNTech/Pfizer, Moderna,Oxford/AstraZeneca and others under Development Against SARSCoV-2 Infection
Journal: Current Medicinal Chemistry
Volume: 29 Issue: 1 Year: 2022 Page: 4-18
Author(s): Michele Costanzo,Maria Anna Rachele De Giglio
Antifungal Drug Discovery, Six New Molecules Patented After 10 Years of Feast:Why do we Need New Patented Drugs Apart from New Strategies?
Journal: Recent Patents on Anti-Infective Drug Discovery
Volume: 2 Issue: 3 Year: 2007 Page: 182-187
Author(s): Vladimir Krcmery, Erich Kalavsky
Identification of Selective Agonists and Antagonists to G Protein-Activated Inwardly Rectifying Potassium Channels: Candidate Medicines for Drug Dependence and Pain
Journal: Current Neuropharmacology
Volume: 9 Issue: 1 Year: 2011 Page: 113-117
Author(s): D. Nishizawa, N. Gajya, K. Ikeda
Pegfilgrastim-Apgf (Nyvepria): Biosimilar USFDA Approval for theTreatment of Chemotherapy-induced Febrile Neutropenia and CurrentUpdates on Clinical Trials
Journal: Current Drug Targets
Volume: 23 Issue: 9 Year: 2022 Page: 924-932
Author(s):
Meet the Guest Editor
Journal: Combinatorial Chemistry & High Throughput Screening
Volume: 7 Issue: 7 Year: 2004 Page: 705-705
Author(s): George G. Harrigan
A Review on Repurposed Drugs and Vaccine Trials for Combating SARS CoV-2
Journal: Current Drug Research Reviews
Volume: 13 Issue: 3 Year: 2021 Page: 203-221
Author(s): Nikita Khanna,Sandip V. Pawar,Anil Kumar
CCR1 Antagonists: What Have We Learned From Clinical Trials
Journal: Current Topics in Medicinal Chemistry
Volume: 10 Issue: 1 Year: 2010 Page: 1268-1277
Author(s): Ronald P. Gladue, Matthew F. Brown, Samuel H. Zwillich